Nufabrx develops proprietary technology to embed active pharmaceutical and therapeutic ingredients into apparel, creating a category it calls HealthWear. Founded in 2011 by Jordan Schindler with work alongside MIT scientists, the company spent years developing its platform. Its first commercial products are capsaicin-infused sleeves for targeted pain relief, and upcoming launches include maternity garments infused with shea butter and shapewear aimed at cellulite. Nufabrx says its products are available at most major retail locations nationwide and online at nufabrx.com, supported by a foundation of clinical data. Financially, the company closed an oversubscribed $10 million Series A equity round and has secured a new credit facility from a leading banking institution. Proceeds are intended to accelerate commercial efforts and R&D to bring dozens of applications to market via direct sales and platform licensing programs.

Total raised

$10M

Funding rounds

2

Latest round

Series A

Latest activity

Oct 2021